12-01-2011: Lab21 Limited has won the BioNow Biomedical Project of the Year Award for its MycAssay product line.  The BioNow Biomedical Project of the Year Award recognises individuals or organisations who have demonstrated an innovative solution to a specific industry problem.

Lab21’s MycAssay Aspergillus and MycAssay Pneumocystis are the world’s first commercial PCR assays for pulmonary fungal infections.  A recent evaluation of MycAssay Aspergillus has shown it to be a sensitive and specific molecular test for the diagnosis of invasive aspergillus.

Hayden Jeffreys, Divisional Director of Products, Lab21 said: “This award for the MycAssay product line recognises the importance of Lab21’s tests for Aspergillus and Pneumocystis, the first products in what is rapidly becoming a portfolio of real-time PCR tests for serious invasive fungal diseases We are pleased with the adoption of these assays into routine use, already demonstrated by increasing sales into 14 countries.”

Contact / Request information

Request further information free of charge:

Facts, background information, dossiers
  • Lab21
  • Aspergillus
  • PCR assays
More about Lab21
  • News

    Lab21 Wins Biomedical Project of the Year Award

    Lab21 Limited has won the BioNow Biomedical Project of the Year Award for its MycAssay product line.  The BioNow Biomedical Project of the Year Award recognises individuals or organisations who have demonstrated an innovative solution to a specific industry problem. Lab21’s MycAssay Aspergi ... more

    Lab21 Announces Positive Results for Aspergillus Detection in Critical Care and Haematology Patients

    Lab21 Limited has announced the completion of an evaluation of a commercial PCR test, its MycAssayTM Aspergillus assay, to detect invasive Aspergillosis (IA) in a mixed population of 158 patients with underlying haematological or critical illness. The prospective evaluation was performed by ... more

    Lab21 Extends CPA Accreditation

    Lab21 Limited has announced that its Clinical Laboratory Division has extended its Clinical Pathology Accreditation (CPA) scope to include Molecular Biology and Virology in addition to Biochemistry. The accreditation was awarded by Clinical Pathology Accreditation (UK), the quality assuranc ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE